IFNA1 and COVID-19: As indicated in Figure 7B, these findings further suggest a model of disease evolution in critically ill COVID-19 patients with pneumonia characterized by an early phase of robust IFN host response to the high replication of the virus followed by a later phase of viral clearance with the suppression of IFN signaling, as supported by previous studies [47].